Skip to content

13F-HR filed by VOYA INVESTMENT MANAGEMENT LLC

VOYA INVESTMENT MANAGEMENT LLC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 2,525 holding rows worth $41,858,236,000.

Accession
0001068837-17-000005
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 3,805 entries on the cover page, a total value of $41,858,236,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $41,858,246,000 with VALUE read as thousands by filing date, 13F file number 028-07292. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerVoya Investment Management Co. LLC 028-01217
  • included managerVoya Investment Trust Co. 028-10070
  • included managerVoya Investments, LLC 028-04547
  • included managerVoya Financial, Inc 028-16916

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IDERA PHARMACEUTICALS INC45168K306COM38,826$58,000thousands by filing date
ATHERSYS INC04744L106COM36,348$56,000thousands by filing date
ECLIPSE RES CORP27890G100COM21,108$56,000thousands by filing date
NOBILIS HEALTH CORP65500B103COM26,206$55,000thousands by filing date
MARCHEX INC56624R108CMN20,566$54,000thousands by filing date
OVERSEAS SHIPHOLDING GROUP I69036R863CL A NEW13,865$53,000thousands by filing date
TERRAVIA HOLDIN88105A106Common Stock46,323$53,000thousands by filing date
NII HLDGS INC COM PAR $0.00162913F508CS24,035$52,000thousands by filing date
VITAL THERAPIES INC92847R104COM11,533$50,000thousands by filing date
CEMPRA INC15130J109COM17,158$48,000thousands by filing date
W & T OFFSHORE INC92922P106COM17,040$47,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM26,392$41,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM18,011$41,000thousands by filing date
BIOSCRIP INC09069N108COM35,932$37,000thousands by filing date
ZAFGEN INC98885E103COM11,162$35,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM24,497$33,000thousands by filing date
INTELSAT S AL5140P101COM12,181$33,000thousands by filing date
SYNTHETIC BIOLOGICS INC87164U102COM38,251$29,000thousands by filing date
TROVAGENE INC897238309COM13,104$28,000thousands by filing date
OVASCIENCE INC69014Q101COM15,549$24,000thousands by filing date
TRANSENTERIX INC89366M201COM NEW17,451$23,000thousands by filing date
Ampio Pharmaceuticals03209T109COM22,886$21,000thousands by filing date
FUELCELL ENERGY INC35952H502COM NEW11,594$20,000thousands by filing date
CYTRX CORP232828509COM PAR $.00135,261$13,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares19,647$13,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001068837-17-000005this filing2017-02-14acceptance time not in the bulk data set